Profiel
Mario Filion is the founder of Alethia Biotherapeutics, Inc. since 2002, holding the title of Chief Scientific Officer & Executive VP.
Former positions include Director-Molecular Genetics at Fortaleza Energy, Inc. and President-Clinical Genomics Division at SignalGene, Inc. Education includes a doctorate from the University of Montréal.
Actieve functies van Mario Filion
| Bedrijven | Functie | Begin |
|---|---|---|
Alethia Biotherapeutics, Inc.
Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets | Oprichter | 01-01-2002 |
Eerdere bekende functies van Mario Filion
| Bedrijven | Functie | Einde |
|---|---|---|
| FORTALEZA ENERGY INC. | Corporate Officer/Principal | - |
SignalGene, Inc. | Corporate Officer/Principal | - |
Opleiding van Mario Filion
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Fortaleza Energy, Inc.
Fortaleza Energy, Inc. Integrated OilEnergy Minerals Engages in the exploration, development and production of crude oil and natural gas | Energy Minerals |
University of Montréal
University of Montréal Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alethia Biotherapeutics, Inc.
Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets | Health Technology |
SignalGene, Inc. |
















